EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2

Mark Thursz, Fouzia Sadiq, Julia A Tree, Peter Karayiannis, David W C Beasley, Wanwissa Dejnirattisai, Juthathip Mongkolsapaya, Gavin Screaton, Matthew Wand, Michael J Elmore, Miles W Carroll, Ian Matthews und 1 weitere

Journal of General Virology · 2023

DOI: 10.1099/jgv.0.001865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Virology, 2023. Verfasst von Mark Thursz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism, Digestion and Reproduction, Imperial College, London W2 1NY, UK. Hauptthemen laut MEDLINE: COVID-19, RNA Viruses. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 2',5'- oligoadenylate synthetase (OAS) – ribonuclease L (RNAseL) - phosphodiesterase 12 (PDE12) pathway is an essential interferon-induced effector mechanism against RNA virus infection. Inhibition of PDE12 leads to selective amplification of RNAseL activity in infected cells. We aimed to investigate PDE12 as a potential pan-RNA virus antiviral drug target and develop PDE12 inhibitors that elicit antiviral activity against a range of viruses. A library of 18 000 small molecules was screened for PDE12 inhibitor activity using a fluorescent probe specific for PDE12. The lead compounds (CO-17 or CO-63) were tested in cell-based antiviral assays using encephalomyocarditis virus (EMCV), hepatitis C virus (HCV), dengue virus (DENV), West Nile virus (WNV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in vitro . Cross reactivity of PDE12 inhibitors with other PDEs and in vivo toxicity were measured. In EMCV assays, CO-17 potentiated the effect of IFNα by 3 log 10 . The compounds were selective for PDE12 when tested against a panel of other PDEs and non-toxic at up to 42 mg kg −1 in rats in vivo . Thus, we have identified PDE12 inhibitors (CO-17 and CO-63), and established the principle that inhibitors of PDE12 have antiviral properties. Early studies suggest these PDE12 inhibitors are well tolerated at the therapeutic range, and reduce viral load in studies of DENV, HCV, WNV and SARS-CoV-2 in human cells and WNV in a mouse model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19RNA VirusesHumansMiceAnimalsRatsAntiviral AgentsSARS-CoV-2Interferon-alphaEncephalomyocarditis virusPhosphoric Diester HydrolasesDiethylstilbestrol

Stichwörter der Autor:innen

2',5'-oligoadenylate synthetase (OAS)West Nile virus (WNV)dengue virus (DENV)hepatitis C virus (HCV)ribonuclease L (RNAseL)severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Substanzen

Antiviral AgentsInterferon-alphaPhosphoric Diester Hydrolasesdiethylstilbestrol monophosphateDiethylstilbestrol

Autor:innen und Institutionen

  • Department of Metabolism, Digestion and Reproduction, Imperial College, London W2 1NY, UK.
  • Present address: Directorate of Research, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
  • UK Health Security Agency, Porton Down, Salisbury, SP4 0JG, UK.
  • University of Nicosia Medical School, Nicosia, Cyprus.
  • RioTech Pharmaceuticals, 49 Arrivato Plaza, St Helens, WA10 1GH, UK.
  • Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555-1019, USA.

Förderung

  • Wellcome Trust
  • European Commission

Zitieren

APA

Thursz, M., Sadiq, F., Tree, J. A., Karayiannis, P., Beasley, D. W. C., Dejnirattisai, W., Mongkolsapaya, J., Screaton, G., Wand, M., Elmore, M. J., Carroll, M. W., Matthews, I., & Thomas, H. (2023). Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2. Journal of General Virology. https://doi.org/10.1099/jgv.0.001865

Vancouver

Thursz M, Sadiq F, Tree JA, Karayiannis P, Beasley DWC, Dejnirattisai W, et al. Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2. Journal of General Virology. 2023. doi:10.1099/jgv.0.001865

BibTeX
@article{Thursz2023,
  author = {Thursz, Mark and Sadiq, Fouzia and Tree, Julia A and Karayiannis, Peter and Beasley, David W C and Dejnirattisai, Wanwissa and Mongkolsapaya, Juthathip and Screaton, Gavin and Wand, Matthew and Elmore, Michael J and Carroll, Miles W and Matthews, Ian and Thomas, Howard},
  title = {Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2},
  journal = {Journal of General Virology},
  year = {2023},
  doi = {10.1099/jgv.0.001865}
}
Kostenlos starten →